Surgical Options in Undifferentiated Thyroid Carcinoma
Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical re...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Lang, Brian Hung-Hin [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2007 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Société Internationale de Chirurgie 2007 |
|---|
| Übergeordnetes Werk: |
Enthalten in: World Journal of Surgery - Springer-Verlag, 1996, 31(2007), 5 vom: 01. Feb., Seite 969-977 |
|---|---|
| Übergeordnetes Werk: |
volume:31 ; year:2007 ; number:5 ; day:01 ; month:02 ; pages:969-977 |
| Links: |
|---|
| DOI / URN: |
10.1007/s00268-007-0776-7 |
|---|
| Katalog-ID: |
SPR003413020 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR003413020 | ||
| 003 | DE-627 | ||
| 005 | 20230519101523.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201001s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00268-007-0776-7 |2 doi | |
| 035 | |a (DE-627)SPR003413020 | ||
| 035 | |a (SPR)s00268-007-0776-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lang, Brian Hung-Hin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Surgical Options in Undifferentiated Thyroid Carcinoma |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Société Internationale de Chirurgie 2007 | ||
| 520 | |a Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. | ||
| 650 | 4 | |a Thyroid Cancer |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Thyroid Carcinoma |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Differentiate Thyroid Cancer |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cervical Lymph Node Metastasis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Anaplastic Thyroid Carcinoma |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Lo, Chung-Yau |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World Journal of Surgery |d Springer-Verlag, 1996 |g 31(2007), 5 vom: 01. Feb., Seite 969-977 |w (DE-627)SPR003391159 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2007 |g number:5 |g day:01 |g month:02 |g pages:969-977 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00268-007-0776-7 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2007 |e 5 |b 01 |c 02 |h 969-977 | ||
| author_variant |
b h h l bhh bhhl c y l cyl |
|---|---|
| matchkey_str |
langbrianhunghinlochungyau:2007----:ugclpiniudfeetaety |
| hierarchy_sort_str |
2007 |
| publishDate |
2007 |
| allfields |
10.1007/s00268-007-0776-7 doi (DE-627)SPR003413020 (SPR)s00268-007-0776-7-e DE-627 ger DE-627 rakwb eng Lang, Brian Hung-Hin verfasserin aut Surgical Options in Undifferentiated Thyroid Carcinoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Société Internationale de Chirurgie 2007 Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. Thyroid Cancer (dpeaa)DE-He213 Thyroid Carcinoma (dpeaa)DE-He213 Differentiate Thyroid Cancer (dpeaa)DE-He213 Cervical Lymph Node Metastasis (dpeaa)DE-He213 Anaplastic Thyroid Carcinoma (dpeaa)DE-He213 Lo, Chung-Yau aut Enthalten in World Journal of Surgery Springer-Verlag, 1996 31(2007), 5 vom: 01. Feb., Seite 969-977 (DE-627)SPR003391159 nnns volume:31 year:2007 number:5 day:01 month:02 pages:969-977 https://dx.doi.org/10.1007/s00268-007-0776-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 31 2007 5 01 02 969-977 |
| spelling |
10.1007/s00268-007-0776-7 doi (DE-627)SPR003413020 (SPR)s00268-007-0776-7-e DE-627 ger DE-627 rakwb eng Lang, Brian Hung-Hin verfasserin aut Surgical Options in Undifferentiated Thyroid Carcinoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Société Internationale de Chirurgie 2007 Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. Thyroid Cancer (dpeaa)DE-He213 Thyroid Carcinoma (dpeaa)DE-He213 Differentiate Thyroid Cancer (dpeaa)DE-He213 Cervical Lymph Node Metastasis (dpeaa)DE-He213 Anaplastic Thyroid Carcinoma (dpeaa)DE-He213 Lo, Chung-Yau aut Enthalten in World Journal of Surgery Springer-Verlag, 1996 31(2007), 5 vom: 01. Feb., Seite 969-977 (DE-627)SPR003391159 nnns volume:31 year:2007 number:5 day:01 month:02 pages:969-977 https://dx.doi.org/10.1007/s00268-007-0776-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 31 2007 5 01 02 969-977 |
| allfields_unstemmed |
10.1007/s00268-007-0776-7 doi (DE-627)SPR003413020 (SPR)s00268-007-0776-7-e DE-627 ger DE-627 rakwb eng Lang, Brian Hung-Hin verfasserin aut Surgical Options in Undifferentiated Thyroid Carcinoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Société Internationale de Chirurgie 2007 Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. Thyroid Cancer (dpeaa)DE-He213 Thyroid Carcinoma (dpeaa)DE-He213 Differentiate Thyroid Cancer (dpeaa)DE-He213 Cervical Lymph Node Metastasis (dpeaa)DE-He213 Anaplastic Thyroid Carcinoma (dpeaa)DE-He213 Lo, Chung-Yau aut Enthalten in World Journal of Surgery Springer-Verlag, 1996 31(2007), 5 vom: 01. Feb., Seite 969-977 (DE-627)SPR003391159 nnns volume:31 year:2007 number:5 day:01 month:02 pages:969-977 https://dx.doi.org/10.1007/s00268-007-0776-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 31 2007 5 01 02 969-977 |
| allfieldsGer |
10.1007/s00268-007-0776-7 doi (DE-627)SPR003413020 (SPR)s00268-007-0776-7-e DE-627 ger DE-627 rakwb eng Lang, Brian Hung-Hin verfasserin aut Surgical Options in Undifferentiated Thyroid Carcinoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Société Internationale de Chirurgie 2007 Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. Thyroid Cancer (dpeaa)DE-He213 Thyroid Carcinoma (dpeaa)DE-He213 Differentiate Thyroid Cancer (dpeaa)DE-He213 Cervical Lymph Node Metastasis (dpeaa)DE-He213 Anaplastic Thyroid Carcinoma (dpeaa)DE-He213 Lo, Chung-Yau aut Enthalten in World Journal of Surgery Springer-Verlag, 1996 31(2007), 5 vom: 01. Feb., Seite 969-977 (DE-627)SPR003391159 nnns volume:31 year:2007 number:5 day:01 month:02 pages:969-977 https://dx.doi.org/10.1007/s00268-007-0776-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 31 2007 5 01 02 969-977 |
| allfieldsSound |
10.1007/s00268-007-0776-7 doi (DE-627)SPR003413020 (SPR)s00268-007-0776-7-e DE-627 ger DE-627 rakwb eng Lang, Brian Hung-Hin verfasserin aut Surgical Options in Undifferentiated Thyroid Carcinoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Société Internationale de Chirurgie 2007 Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. Thyroid Cancer (dpeaa)DE-He213 Thyroid Carcinoma (dpeaa)DE-He213 Differentiate Thyroid Cancer (dpeaa)DE-He213 Cervical Lymph Node Metastasis (dpeaa)DE-He213 Anaplastic Thyroid Carcinoma (dpeaa)DE-He213 Lo, Chung-Yau aut Enthalten in World Journal of Surgery Springer-Verlag, 1996 31(2007), 5 vom: 01. Feb., Seite 969-977 (DE-627)SPR003391159 nnns volume:31 year:2007 number:5 day:01 month:02 pages:969-977 https://dx.doi.org/10.1007/s00268-007-0776-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 31 2007 5 01 02 969-977 |
| language |
English |
| source |
Enthalten in World Journal of Surgery 31(2007), 5 vom: 01. Feb., Seite 969-977 volume:31 year:2007 number:5 day:01 month:02 pages:969-977 |
| sourceStr |
Enthalten in World Journal of Surgery 31(2007), 5 vom: 01. Feb., Seite 969-977 volume:31 year:2007 number:5 day:01 month:02 pages:969-977 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Thyroid Cancer Thyroid Carcinoma Differentiate Thyroid Cancer Cervical Lymph Node Metastasis Anaplastic Thyroid Carcinoma |
| isfreeaccess_bool |
false |
| container_title |
World Journal of Surgery |
| authorswithroles_txt_mv |
Lang, Brian Hung-Hin @@aut@@ Lo, Chung-Yau @@aut@@ |
| publishDateDaySort_date |
2007-02-01T00:00:00Z |
| hierarchy_top_id |
SPR003391159 |
| id |
SPR003413020 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR003413020</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519101523.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201001s2007 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00268-007-0776-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR003413020</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00268-007-0776-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lang, Brian Hung-Hin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Surgical Options in Undifferentiated Thyroid Carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Société Internationale de Chirurgie 2007</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thyroid Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thyroid Carcinoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Differentiate Thyroid Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cervical Lymph Node Metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaplastic Thyroid Carcinoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lo, Chung-Yau</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">World Journal of Surgery</subfield><subfield code="d">Springer-Verlag, 1996</subfield><subfield code="g">31(2007), 5 vom: 01. Feb., Seite 969-977</subfield><subfield code="w">(DE-627)SPR003391159</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:31</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:5</subfield><subfield code="g">day:01</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:969-977</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00268-007-0776-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">31</subfield><subfield code="j">2007</subfield><subfield code="e">5</subfield><subfield code="b">01</subfield><subfield code="c">02</subfield><subfield code="h">969-977</subfield></datafield></record></collection>
|
| author |
Lang, Brian Hung-Hin |
| spellingShingle |
Lang, Brian Hung-Hin misc Thyroid Cancer misc Thyroid Carcinoma misc Differentiate Thyroid Cancer misc Cervical Lymph Node Metastasis misc Anaplastic Thyroid Carcinoma Surgical Options in Undifferentiated Thyroid Carcinoma |
| authorStr |
Lang, Brian Hung-Hin |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR003391159 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Surgical Options in Undifferentiated Thyroid Carcinoma Thyroid Cancer (dpeaa)DE-He213 Thyroid Carcinoma (dpeaa)DE-He213 Differentiate Thyroid Cancer (dpeaa)DE-He213 Cervical Lymph Node Metastasis (dpeaa)DE-He213 Anaplastic Thyroid Carcinoma (dpeaa)DE-He213 |
| topic |
misc Thyroid Cancer misc Thyroid Carcinoma misc Differentiate Thyroid Cancer misc Cervical Lymph Node Metastasis misc Anaplastic Thyroid Carcinoma |
| topic_unstemmed |
misc Thyroid Cancer misc Thyroid Carcinoma misc Differentiate Thyroid Cancer misc Cervical Lymph Node Metastasis misc Anaplastic Thyroid Carcinoma |
| topic_browse |
misc Thyroid Cancer misc Thyroid Carcinoma misc Differentiate Thyroid Cancer misc Cervical Lymph Node Metastasis misc Anaplastic Thyroid Carcinoma |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
World Journal of Surgery |
| hierarchy_parent_id |
SPR003391159 |
| hierarchy_top_title |
World Journal of Surgery |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR003391159 |
| title |
Surgical Options in Undifferentiated Thyroid Carcinoma |
| ctrlnum |
(DE-627)SPR003413020 (SPR)s00268-007-0776-7-e |
| title_full |
Surgical Options in Undifferentiated Thyroid Carcinoma |
| author_sort |
Lang, Brian Hung-Hin |
| journal |
World Journal of Surgery |
| journalStr |
World Journal of Surgery |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2007 |
| contenttype_str_mv |
txt |
| container_start_page |
969 |
| author_browse |
Lang, Brian Hung-Hin Lo, Chung-Yau |
| container_volume |
31 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lang, Brian Hung-Hin |
| doi_str_mv |
10.1007/s00268-007-0776-7 |
| title_sort |
surgical options in undifferentiated thyroid carcinoma |
| title_auth |
Surgical Options in Undifferentiated Thyroid Carcinoma |
| abstract |
Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. © Société Internationale de Chirurgie 2007 |
| abstractGer |
Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. © Société Internationale de Chirurgie 2007 |
| abstract_unstemmed |
Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results. © Société Internationale de Chirurgie 2007 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
| container_issue |
5 |
| title_short |
Surgical Options in Undifferentiated Thyroid Carcinoma |
| url |
https://dx.doi.org/10.1007/s00268-007-0776-7 |
| remote_bool |
true |
| author2 |
Lo, Chung-Yau |
| author2Str |
Lo, Chung-Yau |
| ppnlink |
SPR003391159 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s00268-007-0776-7 |
| up_date |
2024-07-03T19:22:34.648Z |
| _version_ |
1803586953175629824 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR003413020</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519101523.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201001s2007 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00268-007-0776-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR003413020</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00268-007-0776-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lang, Brian Hung-Hin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Surgical Options in Undifferentiated Thyroid Carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Société Internationale de Chirurgie 2007</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It is one of the most aggressive malignancies associated with a poor prognosis. Most patients are elderly presenting as locally advanced disease with nodal and distant metastases. Complete surgical resection is frequently not possible and there is no effective systemic therapy. Aggressive multimodal therapy including surgery, radiation, and chemotherapy is recommended for management. However, because of the rarity of the disease, its aggressiveness and the lack of prospective treatment protocols, nearly all evidence in the literature comes from retrospective case series or cohort studies for selected patients’ subgroups treated over a relatively long study period. Evidence of therapeutic benefit of one treatment option over another is lacking. Prognosis remains dismal with a median survival of 2–12 months Surgery remains an important component of the multimodal therapy and is commonly adopted as primary treatment. Although radical resection should be discouraged, resection without inducing significant morbidity can be considered for good risk patients with resectable tumors. It provides an effective form of palliation with potential cure when combined with postoperative radiotherapy and/or chemotherapy. Patients selected for surgical resection was frequently identified to have improved survival. A regime of preoperative hyperfractionated radiotherapy and doxorubicin followed by surgery when feasible has been documented to achieve local control and avoid tracheostomy for ATC patients. Because of the ineffectiveness of all conventional treatment modalities, novel molecular targeted therapies are being developed to tackling this uniformly fatal disease with promising results.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thyroid Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thyroid Carcinoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Differentiate Thyroid Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cervical Lymph Node Metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaplastic Thyroid Carcinoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lo, Chung-Yau</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">World Journal of Surgery</subfield><subfield code="d">Springer-Verlag, 1996</subfield><subfield code="g">31(2007), 5 vom: 01. Feb., Seite 969-977</subfield><subfield code="w">(DE-627)SPR003391159</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:31</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:5</subfield><subfield code="g">day:01</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:969-977</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00268-007-0776-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">31</subfield><subfield code="j">2007</subfield><subfield code="e">5</subfield><subfield code="b">01</subfield><subfield code="c">02</subfield><subfield code="h">969-977</subfield></datafield></record></collection>
|
| score |
7.4013624 |